Literature DB >> 19237202

Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies.

Valentina Lorenzetti1, Nicholas B Allen, Alex Fornito, Murat Yücel.   

Abstract

BACKGROUND: While there is evidence to suggest that major depressive disorder (MDD) is associated with structural brain abnormalities, the precise nature of these abnormalities remains unclear. AIMS: To review recent structural magnetic resonance imaging (MRI) research findings in MDD while considering the potential influence of key clinical and demographic variables.
METHOD: A selective review of all T1-weighted structural MRI studies published between 2000 and 2007 in adult samples of MDD patients.
RESULTS: Volumetric reductions of the hippocampus, basal ganglia and OFC and SGPFC are consistently found in MDD patients, with more persistent forms of MDD (e.g., multiple episodes or repeated relapses, longer illness duration) being associated with greater impact on regional brain volumes. Gender, medication, stage of illness, and family history all affect the nature of the findings in a regionally specific manner. LIMITATIONS: Overall, differences between the samples in factors such as illness severity, medication, gender and family history of mental illness makes difficult to identify their confounding effects on the observed neuroanatomical changes. Also, the tracing protocols used for particular brain regions were different amongst the reviewed studies, making difficult to compare their findings.
CONCLUSIONS: The data support the notion that MDD involves pathological alterations of limbic and cortical structures, and that they are generally more apparent in patients with more severe or persistent forms of the illness.

Entities:  

Mesh:

Year:  2009        PMID: 19237202     DOI: 10.1016/j.jad.2008.11.021

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  171 in total

1.  Hippocampal volume differences in Gulf War veterans with current versus lifetime posttraumatic stress disorder symptoms.

Authors:  Brigitte A Apfel; Jessica Ross; Jennifer Hlavin; Dieter J Meyerhoff; Thomas J Metzler; Charles R Marmar; Michael W Weiner; Norbert Schuff; Thomas C Neylan
Journal:  Biol Psychiatry       Date:  2010-11-20       Impact factor: 13.382

2.  [S3 guidelines on unipolar depression].

Authors:  M Bauer
Journal:  Nervenarzt       Date:  2010-09       Impact factor: 1.214

3.  Chronic variable stress impairs energy metabolism in prefrontal cortex and hippocampus of rats: prevention by chronic antioxidant treatment.

Authors:  Bárbara Tagliari; Cristie G Noschang; Andréia G K Ferreira; Otávio A Ferrari; Luciane R Feksa; Clovis M D Wannmacher; Carla Dalmaz; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2010-05-27       Impact factor: 3.584

Review 4.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

5.  Associations of current and remitted major depressive disorder with brain atrophy: the AGES-Reykjavik Study.

Authors:  M I Geerlings; S Sigurdsson; G Eiriksdottir; M E Garcia; T B Harris; T Sigurdsson; V Gudnason; L J Launer
Journal:  Psychol Med       Date:  2012-05-30       Impact factor: 7.723

6.  Functional brain activation to emotionally valenced faces in school-aged children with a history of preschool-onset major depression.

Authors:  Deanna M Barch; Michael S Gaffrey; Kelly N Botteron; Andrew C Belden; Joan L Luby
Journal:  Biol Psychiatry       Date:  2012-07-07       Impact factor: 13.382

Review 7.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

8.  Antidepressants normalize the default mode network in patients with dysthymia.

Authors:  Jonathan Posner; David J Hellerstein; Inbal Gat; Anna Mechling; Kristin Klahr; Zhishun Wang; Patrick J McGrath; Jonathan W Stewart; Bradley S Peterson
Journal:  JAMA Psychiatry       Date:  2013-04       Impact factor: 21.596

9.  Prefrontal cortical deficits in type 1 diabetes mellitus: brain correlates of comorbid depression.

Authors:  In Kyoon Lyoo; Sujung Yoon; Alan M Jacobson; Jaeuk Hwang; Gail Musen; Jieun E Kim; Donald C Simonson; Sujin Bae; Nicolas Bolo; Dajung J Kim; Katie Weinger; Junghyun H Lee; Christopher M Ryan; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2012-12

10.  Basal ganglia morphology links the metabolic syndrome and depressive symptoms.

Authors:  Ikechukwu C Onyewuenyi; Matthew F Muldoon; Israel C Christie; Kirk I Erickson; Peter J Gianaros
Journal:  Physiol Behav       Date:  2013-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.